摘要
目的:探讨聚乙二醇化干扰素α-2a治疗HBeAg阴性的慢性乙型肝炎的临床效果和经济效果。方法:运用成本-效果分析法对56例HBeAg阴性的慢性乙型肝炎患者分别用聚乙二醇化干扰素α-2a和干扰素两种方案治疗的结果进行比较。结果:聚乙二醇化干扰素组疗效对比干扰素组有显著差异,且?
OBJECTIVE： To discuss the clinical efficacy and economic effects of PEG - IFNα - 2a in the treatment of type B chronic hepatitis. METHODS： The cost- effectiveness of PEG- IFNα- 2a versus interferon （IFN） in the treatment of type B chronic hepatitis was evaluated comparatively. RESULTS： There were significant differences in clinical efficacy between PEG- IFNα- 2a and interferon （IFN） in the treatment of type B chronic hepatitis, and the costeffectiveness ratio in the former group was lower than in the latter one. CONCLUSION： As a new antiviral drug, PEG - IFNα - 2a showed a satisfactory cost - effectiveness ratio in the treatment of type B chronic hepatitis and its development enjoys promising future.
出处
《中国医院用药评价与分析》
2008年第9期683-685,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
